DR5 Recombinant Monoclonal Antibody

The DR5 Recombinant Monoclonal Antibody is applicable for the following applications: ELISA. Host: Human. Species Reactivity: Human (Homo sapiens) . Immunogen: Recombinant Human DR5 protein. Accession Number: O14763. Target Synonyms: rotein; Apoptosis inducing protein TRICK2A/2B; Apoptosis inducing receptor TRAIL R2; CD262; CD262 antigen; Cytotoxic TRAIL receptor 2; Death domain containing receptor for TRAIL/Apo 2L; Death receptor 5; DR5; KILLER; KILLER/DR5; OTTHUMP00000123492; OTTHUMP00000123493; p53 regulated DNA damage inducible cell death receptor (killer) ; TNF related apoptosis inducing ligand receptor 2; TNF-related apoptosis-inducing ligand receptor 2; TNFRSF10B; TR10B_HUMAN; TRAIL R2; TRAIL receptor 2; TRAIL-R2; TRAILR2; TRICK2; TRICK2A; TRICK2B; TRICKB; Tumor necrosis factor receptor like protein ZTNFR9; Tumor necrosis factor receptor superfamily member 10B; Tumor necrosis factor receptor superfamily; member 10b; ZTNFR9; Conatumumab. Restrictions: For Research Use Only. Not for use in diagnostic procedures.

Product Specifications

Short Description

The DR5 Recombinant Monoclonal Antibody is applicable for the following applications: ELISA

Accession Number

O14763

Host

Human

Reactivity

Human (Homo sapiens)

Immunogen

Recombinant Human DR5 protein

Target

TNFRSF10B

Clonality

Recombinant Monoclonal

Clone

1D10

Conjugation

Unconjugated. Conjugated antibodies are available (Biotin, FITC and HRP), please inquire.

Applications

ELISA

Field of Research

Others

Purification

Affinity chromatography

Concentration

Lot specific. Please inquire or refer to the datasheet included in the product pouch.

Format

Liquid

Buffer

0.03% Proclin 300, 50% Glycerol, 0.01M PBS, pH 7.4

Shipping Conditions

Ice packs

Storage Conditions

2°C to 8°C for frequent use, -20°C for 12 months. Avoid repeated freeze/thaw cycles.

Fragment

IgG1

Target Alternative Name

Rotein; Apoptosis inducing protein TRICK2A/2B; Apoptosis inducing receptor TRAIL R2; CD262; CD262 antigen; Cytotoxic TRAIL receptor 2; Death domain containing receptor for TRAIL/Apo 2L; Death receptor 5; DR5; KILLER; KILLER/DR5; OTTHUMP00000123492; OTTHUMP00000123493; p53 regulated DNA damage inducible cell death receptor (killer) ; TNF related apoptosis inducing ligand receptor 2; TNF-related apoptosis-inducing ligand receptor 2; TNFRSF10B; TR10B_HUMAN; TRAIL R2; TRAIL receptor 2; TRAIL-R2; TRAILR2; TRICK2; TRICK2A; TRICK2B; TRICKB; Tumor necrosis factor receptor like protein ZTNFR9; Tumor necrosis factor receptor superfamily member 10B; Tumor necrosis factor receptor superfamily; member 10b; ZTNFR9; Conatumumab